For the Prevention and treatment of shortness of breath in patients with Chronic Obstructive Pulmonary Disease (COPD), Chronic Bronchitis, Mild to moderate asthma.

Headache, dizziness, dry mouth.

Discontinue immediately if paradoxical bronchospasm, hypersensitivity or visual disturbances occur Use with caution in patients with cardiovascular system disorders and narrow angle glaucoma.

Ipratropium bromide is an anticholinergic and its use may increase intraocular pressure. This may result in precipitation or worsening of narrow-angle glaucoma. Therefore, it should be used with caution in patients with narrow-angle glaucoma. Patients should avoid spraying ipratropium bromide inhaler into the eye.

Ipratropium bromide can produce paradoxical bronchospasm that can be life threatening. If this occurs, treatment with ipratropium bromide should be stopped and other treatments considered.

Hypersensitivity reactions including urticaria, angioedema, rash, bronchospasm, anaphylaxis and oropharyngeal edema, may occur after the a dministration of ipratropium bromide. If such a reaction occurs, therapy with ipratropium bromide should be stopped at once and alternative treatment should be considered.

Always consult your physician before using any medicine.

Administration of ipratropium bromide with beta-adrenergics and xanthine preparations may intensify the bronchodilator effect.Co-Administration of ipratropium bromide with other anticholinergic drugs should be avoided, as this may lead to an increase in anticholinergic adverse effects.